The Lancet | Agomelatine in children and adolescents with major depressive disorder @TheLancetTV | Uploaded February 2023 | Updated October 2024, 1 hour ago.
Prof Bruno Falissard introduces the paper on the safety and efficacy of agomelatine in combination with psychosocial counselling in children and adolescents with major depressive disorder.

Read the full article in The Lancet Psychiatry, Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries: thelancet.com/journals/lanpsy/article/PIIS2215-0366(21)00390-4/fulltext?dgcid=youtube_video_lanpsy

Visit The Lancet Psychiatry at thelancet.com/journals/lanpsy/home?dgcid=youtube_video_lanpsy
Find out more at thelancet.com/?dgcid=youtube_video_lancet_lancet

* * *
Continue this conversation on social! Follow us today at…
Twitter.com/TheLancet
facebook.com/TheLancetMedicalJournal
LinkedIn.com/company/the-lancet